Skip to main content
. 2022 Nov 29;29(4):979–987. doi: 10.1111/cns.14033

TABLE 1.

Baseline characteristics and outcomes of ICH patients with different admission blood glucose levels

All subjects (N = 1372) Admission blood glucose <7.8 (N = 984) Admission blood glucose ≥7.8 (N = 388) p‐value
Age, y, Mean ± SD 62.3 ± 11.6 62.2 ± 11.5 62.6 ± 11.9 0.158
Male, (n, %) 904 (65.9) 651 (66.2) 253 (65.2) 0.738
Hypertension, (n, %) 957 (69.8) 660 (67.1) 297 (76.5) 0.002
DM, (n, %) 281 (20.5) 98 (10.0) 183 (47.2) <0.001
Time from symptom onset to admission, h, median (IQR) 3 (2, 7.5) 3.5 (2, 8) 3 (2, 6) 0.012
Admission SBP ≥140 mmHg, (n, %) 1219 (88.8) 869 (88.3) 350 (90.2) 0.316
HBA1c ≥6.5%, (n, %) 397 (28.9) 158 (16.1) 239 (61.6) <0.001
Admission blood glucose, mmol/L, median (IQR) 6.5 (5.5, 8.1) 5.9 (5.3, 6.6) 9.5 (8.5, 11.5) <0.001
HBA1c, %, median (IQR) 5.7 (5.3, 6.2) 5.6 (5.3, 6.0) 6.4 (5.6, 8.0) <0.001
Infratentorial hemorrhage, (n, %) 159 (12.0) 90 (9.5) 69 (18.3) <0.001
Hematoma volume, ml, median (IQR) 10.0 (4.6, 24.0) 10.0 (4.5, 20.0) 10.0 (4.3, 27.0) 0.124
IVH, (n, %) 207 (15.1) 118 (12.0) 89 (22.9) <0.001
GCS, median (IQR) 14 (12, 15) 14 (13, 15) 13 (9, 15) <0.001
Surgical treatment, (n, %) 230 (16.8) 129 (13.1) 101 (26%) <0.001
Length of hospitalization, days, median (IQR) 16.0 (11.0, 22.0) 16.0 (12.0, 21.0) 16.0 (9.0, 23.0) 0.685
Pulmonary infection, (n, %) 179 (13.0) 101 (10.3) 78 (20.1) <0.001
30‐day mRS (3–6), (n, %) 821/1331 a (62.7) 547/953 a (57.4) 274/378 a (72.5) <0.001
90‐day mRS (3–6), (n, %) 679/1331 a (51.0) 440/953 a (46.2) 239/378 a (63.2) <0.001
In‐hospital death, (n, %) 48 (3.5) 23 (2.3) 25 (6.4) <0.001
30‐day death, (n, %) 155/1331 a (11.6) 74/953 a (7.8) 81/378 a (21.4) <0.001
90‐day death, (n, %) 196/1331 a (14.7) 106/953 a (11.1) 90/378 a (23.8) <0.001

Abbreviations: DM, diabetes mellitus; GCS, Glasgow Coma Scale; HbA1c, Glycosylated hemoglobin A1c; IQR indicates interquartile range; IVH, intraventricular hemorrhage; mRS, modified Rankin Scale; SBP, systolic blood pressure; SD, standard deviation.

a

41 patients lacked 30‐ and 90‐days follow‐up data, of which 31 with non‐hyperglycemia and 10 with hyperglycemia.